Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Akebia Therapeutics Total Assets 2013-2025 | AKBA

Akebia Therapeutics total assets from 2013 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Akebia Therapeutics Annual Total Assets
(Millions of US $)
2024 $221
2023 $242
2022 $356
2021 $529
2020 $644
2019 $771
2018 $997
2017 $364
2016 $300
2015 $143
2014 $111
2013 $35
2012 $2
Akebia Therapeutics Quarterly Total Assets
(Millions of US $)
2025-03-31 $310
2024-12-31 $221
2024-09-30 $207
2024-06-30 $220
2024-03-31 $225
2023-12-31 $242
2023-09-30 $235
2023-06-30 $254
2023-03-31 $277
2022-12-31 $356
2022-09-30 $436
2022-06-30 $522
2022-03-31 $535
2021-12-31 $529
2021-09-30 $602
2021-06-30 $612
2021-03-31 $629
2020-12-31 $644
2020-09-30 $676
2020-06-30 $745
2020-03-31 $788
2019-12-31 $771
2019-09-30 $795
2019-06-30 $824
2019-03-31 $891
2018-12-31 $997
2018-09-30 $404
2018-06-30 $414
2018-03-31 $443
2017-12-31 $364
2017-09-30 $339
2017-06-30 $337
2017-03-31 $259
2016-12-31 $300
2016-09-30 $169
2016-06-30 $196
2016-03-31 $221
2015-12-31 $143
2015-09-30 $160
2015-06-30 $156
2015-03-31 $103
2014-12-31 $111
2014-09-30 $120
2014-06-30 $126
2014-03-31 $134
2013-12-31 $35
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.738B $0.160B
Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.493B 31.32
Zoetis (ZTS) United States $71.874B 26.82
Daiichi Sankyo, - (DSNKY) Japan $49.349B 25.11
Takeda Pharmaceutical (TAK) Japan $45.565B 9.06
Sandoz Group AG (SDZNY) Switzerland $21.424B 0.00
Summit Therapeutics (SMMT) United States $18.871B 0.00
Merck (MKKGY) Germany $17.157B 12.57
United Therapeutics (UTHR) United States $13.969B 12.36
Shionogi (SGIOY) Japan $13.560B 13.59
Neurocrine Biosciences (NBIX) United States $11.931B 40.87
IPSEN (IPSEY) France $9.964B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.038B 65.35
Stevanato Group S.p.A (STVN) Italy $7.265B 44.43
Madrigal Pharmaceuticals (MDGL) United States $6.156B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.631B 0.00
Ionis Pharmaceuticals (IONS) United States $5.332B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.694B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.966B 10.39
Crinetics Pharmaceuticals (CRNX) United States $2.804B 0.00
Hypermarcas (HYPMY) Brazil $2.702B 17.77
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.279B 12.32
BioCryst Pharmaceuticals (BCRX) United States $2.107B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.713B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.665B 0.00
Indivior (INDV) United States $1.557B 6.60
Evotec AG (EVO) Germany $1.424B 0.00
ARS Pharmaceuticals (SPRY) United States $1.397B 0.00
Guardian Pharmacy Services (GRDN) United States $1.396B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 22.54
Harrow (HROW) United States $0.981B 0.00
Ardelyx (ARDX) United States $0.955B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.885B 0.00
Enliven Therapeutics (ELVN) United States $0.831B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.769B 0.00
AleAnna (ANNA) United States $0.680B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.05
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Xencor (XNCR) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Bioventus (BVS) United States $0.534B 13.54
Savara (SVRA) United States $0.503B 0.00
Relay Therapeutics (RLAY) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.484B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Altimmune (ALT) United States $0.453B 0.00
CytoDyn (CYDY) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.438B 9.15
Oruka Therapeutics (ORKA) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.374B 10.12
Heron Therapeutics (HRTX) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.52
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.225B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.208B 0.00
OmniAb (OABI) United States $0.175B 0.00
Avita Medical (RCEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
Esperion Therapeutics (ESPR) United States $0.169B 0.00
4D Molecular Therapeutics (FDMT) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Wellgistics Health (WGRX) United States $0.162B 0.00
Liminatus Pharma (LIMN) $0.160B 0.00
Journey Medical (DERM) United States $0.157B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Aclaris Therapeutics (ACRS) United States $0.140B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Aldeyra Therapeutics (ALDX) United States $0.135B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Larimar Therapeutics (LRMR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
VAXART, INC (VXRT) United States $0.104B 0.00
Lexeo Therapeutics (LXEO) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
ESSA Pharma (EPIX) Canada $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Surrozen (SRZN) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00